Julia Rohlhill
Associate Director - Viral Vector Sciences Legend Biotech
Seminars
Thursday 25th February 2027
Chair’s Opening Remarks
8:55 am
Thursday 25th February 2027
Panel Discussion: Establishing Risk-Based Process Development Decision Frameworks to Accelerate Clinical Progression
11:00 am
- Defining fit-for-purpose process performance criteria to accelerate clinical progression while maintaining robust, reliable and reproducible viral vector manufacturing
- Assessing technology adoption and supplier diversification strategies to reduce operational risk while maximizing value from established manufacturing platforms
- Balancing process optimization efforts against program timelines, manufacturing costs and patient demand to enable data-driven development decisions
Thursday 25th February 2027
Roundtable Discussion: Overcoming Tech Transfer Bottlenecks Through Better Sponsor-CDMO Collaboration to Accelerate Manufacturing Readiness
1:45 pm
- Identifying documentation gaps, batch record deficiencies and training challenges to improve first-time-right tech transfer execution
- Strengthening sponsor-CDMO communication practices to reduce transfer failures, rework cycles and manufacturing delays
- Benchmarking successful transfer approaches and lessons learned from failures to accelerate clinical timelines and patient access
Thursday 25th February 2027
Chair’s Closing Remarks
3:45 pm
